TuHURA Biosciences approved salary increases for CEO James A. Bianco to $499,000 and CFO Dan Dearborn to $375,000, effective January 1, 2025, along with stock options for both executives, with Bianco receiving options for 1,065,990 shares and Dearborn for 489,848 shares at an exercise price of $4.94.